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Summary
Systemic infection with Streptococcus pneumoniae
is associated with a vigorous pro-inflammatory
response to structurally complex cell wall fragments
(PnCW) that are shed during cell growth and
antibiotic-induced autolysis. Consistent with previ-
ous studies, inflammatory cytokine production
induced by PnCW was dependent on TLR2 but
independent of NOD2, a cytoplasmic NLR protein.
However, in parallel with the pro-inflammatory
response, we found that PnCW also induced pro-
digious secretion of anti-inflammatory IL-10 from
macrophages. This response was dependent on
TLR2, but also involved NOD2 as absence of NOD2-
reduced IL-10 secretion in response to cell wall and
translated into diminished downstream effects
on IL-10-regulated target gene expression. PnCW-
mediated production of IL-10 via TLR2 required RIPK2
a kinase required for NOD2 function, and MyD88 but
differed from that known for zymosan in that ERK
pathway activation was not detected. As mutations in
NOD2 are linked to aberrant immune responses, the
temporal and quantitative effects of activation of the
TLR2-NOD2-RIPK2 pathway on IL-10 secretion may
affect the balance between pro- and anti-inflammatory
responses to Gram-positive bacteria.
Introduction
IL-10 secretion from T cells, macrophages and dendritic
cells is an essential regulatory mechanism to temper
excessive inflammatory responses (Murray, 2006). Mice
lacking IL-10 are extremely sensitive to a wide variety of
pro-inflammatory stimuli including LPS, and systemic
infections with bacteria and parasites that provoke a
strong inflammatory response (Murray, 2006). In all
cases, IL-10 is required to restrain the inflammatory
response and protect the host against the damaging
effects of pro-inflammatory cytokines. Systemic infection
with S. pneumoniae provokes a generalized inflammatory
response linked with devastating neurological sequelae
and a fatality rate of ~15% (Tuomanen et al., 1995).
Administration of purified pneumococcal cell wall (PnCW)
recapitulates the majority of the inflammatory responses
observed in systemic S. pneumoniae infection, suggest-
ing that the pro-inflammatory properties of PnCW are a
primary driver of inflammatory pathology (Moreillon and
Majcherczyk, 2003; Fillon et al., 2006; Orihuela et al.,
2006). Because PnCW is mainly composed of peptidogly-
can, teichoic acid, cell wall linked proteins and lipoteichoic
acids, TLR2 is considered especially important in the
process of PnCW detection by macrophages and den-
dritic cells that are then stimulated to produce inflam-
matory cytokines (Yoshimura et al., 1999). IL-10 can
modulate PnCW induced inflammation (Orihuela et al.,
2006), but the mechanism leading to IL-10 production is
entirely unclear.
Modulation of inflammation has been suggested to
involve NOD2, a cytoplasmic protein of the larger NLR
family (Inohara and Nunez, 2003; Inohara et al., 2005;
Murray, 2005; Strober et al., 2006; Kanneganti et al.,
2007). For example, single nucleotide polymorphisms in
NOD2 have been observed at an increased frequency in
Crohn’s disease (Lesage et al., 2002). However, several
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loss-of-function mice in the Nod2 gene do not have gut
immunopathology when maintained under normal condi-
tions (Pauleau and Murray, 2003; Kobayashi et al., 2005;
Maeda et al., 2005; Mariathasan et al., 2006; Barreau
et al., 2007). These data are consistent with the fact
that some people have mutations in one or both NOD2
alleles but have no clinical inflammatory bowel disease
(Hugot et al., 2007). Thus NOD2 likely plays a role in
more complex pathways modulating pro-inflammatory
responses (Strober et al., 2007; Xavier and Podolsky,
2007).
NOD2-deficient mice, their immune cells and human
cells bearing predicted loss-of-function NOD2 alleles, are
non-responsive to muramyl dipeptide (MDP), a ‘minimal’
component of bacterial peptidoglycan able to induce pro-
inflammatory responses. A second pathway of MDP
sensing appears to be involved in IL-1b processing and is
mediated by NLR family members Cryopyrin (NLRP3) and
Nalp1 (NLRP1) (Faustin et al., 2007; Pan et al., 2007;
Marina-Garcia et al., 2008). At this stage it is unclear
whether human cells bearing two copies of the NOD2
frame-shift mutation are completely non-responsive to
MDP because the truncated mutant protein should still be
expressed. Compared with other bacterial components
such as LPS, peptidoglycan or CpG DNA, MDP is a very
weak agonist of myeloid-derived cells, especially when
considered by molar comparison. However, MDP syner-
gizes with other TLR agonists to stimulate cytokine,
chemokine and nitric oxide production. This effect is the
basis of variants of the ‘MDP synergy’ assay, a common
‘readout’ of NOD2 function. In contrast to the lack of MDP
responsiveness, macrophages from all NOD2-deficient
mice have been generally reported to have ‘normal’
responses to highly defined TLR agonists. At present, the
specific roles of MDP, the origin of MDP in mammalian
infection systems and the link between NOD2 and MDP
remain unresolved.
In the studies described here, we observed that TLR2
and NOD2 were together responsible for IL-10 production
when macrophages were exposed to PnCW. By contrast,
inflammatory cytokine production in response to PnCW
was TLR2 dependent and NOD2-independent. Our
studies reveal an unexpected pathway of signal integra-
tion in response to a complex microbial product that
stimulates multiple signalling pathways in macrophages.
Results
When S. pneumoniae grow in vivo, cell wall components
are released into the host environment by several pro-
cesses: cell wall turnover that occurs during normal
growth, antibiotics that induce autolysis, and subpopula-
tions that undergo spontaneous autolysis as a mecha-
nism of interbacterial gene transfer. The latter process
lead in part to the discovery of DNA as the source of
genetic information. Released cell wall fragments stimu-
late a complex pathway of local and systemic inflamma-
tory responses including neuronal damage and memory
loss (Tuomanen et al., 1995). Because cell wall fragments
derived from yeast (zymosan) induce robust IL-10 secre-
tion from myeloid-derived cells (Dillon et al., 2004; 2006;
Rogers et al., 2005; Slack et al., 2007), we tested if puri-
fied PnCW (Fillon et al., 2006) also induced IL-10 produc-
tion from bone marrow-derived macrophages (BMDMs).
PnCW induced previously unsuspected high amounts of
IL-10 (Fig. 1). As purified PnCW is composed primarily of
peptidoglycan, a TLR2 agonist, this response was predict-
ably TLR2 dependent (Fig. 1). In parallel experiments we
also observed that IL-10 and IL-10 mRNA production in
response to PnCW was also dependent on NOD2
(Figs 1B, D and E). The reduction in IL-10 production from
PnCW-stimulated NOD-deficient macrophages was not to
the same extent as Tlr2 -/- BMDMs but nevertheless
highly reproducible. We also observed that BMDMs
derived from Tlr2 -/-;Nod2 -/- mice secreted undetectable
IL-10, demonstrating that TLR2 and NOD2 might function
in the same or related pathways for IL-10 production
(Figs 1B, D and E). By contrast, IL-10 production in
response to LPS was indistinguishable in Tlr2-/-, Nod2-/-
or Tlr2 -/-;Nod2 -/- cells (Fig. 1C). We tested if NOD2 was
required for IL-10 production in response to Pam3CSK4, a
synthetic lipid that signals via exclusively TLR2. We
observed that Nod2 -/- BMDMs produced IL-10 in
response to Pam3CSK4 similar to control cells (data not
shown). In contrast, Pam3CSK4 did not induce IL-10 in
Tlr2 -/- or Tlr2 -/-;Nod2 -/- cells as expected (data not
shown). NOD2 was therefore not required for the ‘canoni-
cal’ TLR2 activation pathway stimulated by Pam3CSK4
but was important to the physiological PnCW stimulus.
Because PnCW is a complex macromolecule, we
tested its cellular fate after exposure to BMDMs. We visu-
alized PnCW fragments in macrophages through the
use of FITC-labelled PnCW (Fig. 1F and G). Macroph-
ages consumed all the PnCW over a period of ~24 h and
thereafter, the PnCW remained internalized and appar-
ently unchanged over 7 days when the experiments were
terminated. Comparing these data with the kinetics of
cytokine secretion, we suspect that macrophages are
stimulated with early, external contact with PnCW. By
contrast, phagocytosed PnCW appeared to persist within
macrophages. Further experiments will be necessary to
determine if macrophages can generate MDP from the
PnCW and any signalling connections between NOD2
and in-dwelling PnCW.
We next asked how broadly NOD2 influenced overall
macrophage transcriptional responses to PnCW. We per-
formed transcriptome analysis of BMDMs derived from
background-matched C57BL/6 Nod2 + /+ or Nod2 -/- mice
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stimulated for 0, 1 or 4 h with PnCW at a concentration
and conditions identical to that used for the experiments in
Fig. 1. We analysed the data first by principal component
analysis (data not shown) and then by ordering gene
expression according to degree of induction relative to the
untreated (0 h) time point data (Table 1). We observed
that the absence of NOD2 had limited effects on the
overall inflammatory response to PnCW (Table 1, Fig. 2A)
consistent with the notion that other receptors, especially
TLR2, mediate a strong cellular activation by PnCW. Of
the mRNAs whose expression was altered, we noted that
IL-10 mRNA expression was reduced in NOD2-deficient
cells relative to controls consistent with the ELISA and
mRNA data shown in Fig. 1. Because IL-10 has essential
autocrine-paracrine inhibitory effects on activated mac-
rophages, we next asked if a panel of known downstream
target genes of IL-10 signalling (Lang et al., 2002; El
Kasmi et al., 2007) were affected by the reduction of IL-10
after PnCW stimulation of NOD2-deficient macrophages.
We observed that expression of multiple IL-10 target
genes was lowered relative to controls in NOD2-deficient
macrophages at 4 h post stimulation (Fig. 2B). This is
consistent with the data that PnCW stimulates IL-10
production in a NOD2-dependent way that leads, in part,
to autocrine-paracrine downstream effects on IL-10-
responsive gene expression.
By contrast to the requirement for both TLR2 and
NOD2 in IL-10 production, we observed that all tested
Fig. 1. Combined signals from TLR2 and NOD2 are required for PnCW-induced IL-10 production.
A. Schematic representation of the composition of PnCW obtained by biochemical purification from whole lysed pneumococci. The upper part
of the figure is cartoon of the bacteria cell membrane and wall indicating that the wall composed primarily of peptidoglycan, to which multiple
proteins, lipopeptides and lipids are tethered, surrounds the cell membrane of pneumococci. Following purification, PnCW is predominantly
peptidoglycan and teichoic acids. This fraction is particulate is nature, analogous to zymosan fractions from yeast cell walls.
B. IL-10 production from BMDMs stimulated with PnCW measured over time by ELISA. Results are combined from independent experiments
(n = 7).
C. IL-10 production from LPS stimulation of BMDMs from the same genotypes used in (B).
D. Northern blotting analysis of IL-10 mRNA over time (h) following PnCW stimulation of BMDMs from the indicated genotypes. Data from
Nod2 -/-; Tlr2 -/- BMDMs were obtained from a different part of the gel as shown the separation from the other part of the gel.
E. qRT-PCR analysis of IL-10 mRNA production following PnCW stimulation. Data points are averages of duplicate samples. Data are
representative of three independent experiments.
F. Confocal microscopy to follow the fate of PnCW after contact with BMDMs. FITC-labelled PnCW was added to C57BL/6 BMDMs and
followed over time. Representative images at times 0, 5, 24 and 48 h are shown. At each time, cultures were fixed and labelled with phalloidin
to visualize actin. Note that the FITC signal is not visible until sufficient PnCW particle have been phagocytosed and concentrated inside
macrophages (24 h). All images were collected using a 10¥ objective, except the 48 h time point (20¥).
G. Higher power image of PnCW inside BMDMs at 48 h (40¥ objective).
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pro-inflammatory genes induced by PnCW were depen-
dent on TLR2 (Fig. 3), but independent of NOD2 as
shown by the microarray data (Table 1). These results are
consistent with the notion that TLR2 is the primary
pathway by which macrophages detect PnCW and that
NOD2 plays a downstream role in fine tuning the signal-
ling response, in this case by regulating IL-10 production.
NOD2 has been reported to form heterotypic com-
plexes with another CARD domain protein, RIPK2
(Kobayashi et al., 2002; Park et al., 2007; Hasegawa
et al., 2008). Like NOD2-deficient cells, macrophages
lacking RIPK2 cannot respond to MDP, suggesting that
NOD2 and RIPK2 function in the same pathway for MDP
responsiveness (Park et al., 2007). Furthermore, RIPK2
is also required for NOD1 function (which does not ‘sense’
MDP), suggesting that RIPK2 is genetically and biochemi-
cally linked to both NOD1 and NOD2 activity (Park et al.,
2007). We therefore used macrophages derived from two
Table 1. Gene expression increased by PnCW treatment.
Gene Rank (WT) Fold (4 h) Rank (Nod2 -/-) Fold (4 h) P (time) P (genotype)
Gm 1960 1 222.14 1 205.56 1.41E-13 0.5314
Irg1 2 124.62 2 145.62 4.32E-11 0.8515
Cxcl1 3 102.85 4 111.82 2.17E-11 0.3880
Tnf 4 82.04 3 124.60 1.02E-11 0.8967
Cxcl1 5 78.06 5 102.79 4.75E-11 0.3036
Ccl3 6 77.61 6 76.38 4.39E-11 0.9913
Saa3 7 76.27 8 54.01 2.37E-14 0.1997
Ptgs2 8 57.72 16 29.27 4.13E-09 0.9574
Ccl4 9 54.47 14 32.23 3.61E-12 0.6201
Il1b 10 51.93 15 32.00 8.30E-07 0.7485
Gpr109a 11 51.73 10 37.09 7.80E-14 0.2307
Slc7a11 12 51.72 19 24.34 4.11E-14 0.6030
Ptgs2 13 51.63 46 16.03 8.02E-08 0.1154
Il1a 14 45.04 50 15.37 6.39E-07 0.7571
Il6 15 44.03 11 35.24 1.02E-06 0.3773
Socs3 16 43.81 13 32.65 2.46E-11 0.2271
Socs3 17 40.92 17 26.16 1.79E-11 0.4451
Fpr1 18 38.41 26 21.24 2.66E-09 0.8110
Tnfaip3 19 36.91 20 24.25 6.30E-09 0.4238
Cxcl2 20 36.81 7 60.84 6.79E-14 0.9650
BB548587 21 36.54 71 11.55 1.85E-06 0.7213
Tnfsf9 22 35.17 64 12.63 5.17E-08 0.9962
Socs3 23 35.10 18 25.02 1.24E-12 0.2296
Ccl2 24 34.01 21 23.20 1.41E-09 0.5926
Ccl7 25 33.98 9 42.02 8.91E-10 0.3433
Fpr-rs2 26 31.15 27 21.21 3.19E-12 0.6983
Il1rn 27 29.49 69 11.71 2.74E-10 0.0624
Ets2 28 29.25 49 15.50 3.77E-09 0.5326
Ccrl2 29 29.13 30 19.91 2.75E-08 0.7250
LOC622976 30 28.83 12 33.45 6.43E-12 0.1185
Il1rn 31 28.08 32 18.99 4.52E-11 0.1198
Tnfaip3 32 27.38 24 21.82 1.42E-10 0.8902
Zc3h12c 33 25.12 23 22.49 7.12E-10 0.3216
Ccl12 34 25.12 59 13.15 1.25E-08 0.2671
Cdc42ep2 35 24.16 44 16.31 1.03E-08 0.7966
Gpr84 36 23.46 31 19.54 3.15E-10 0.2886
Il1rn 37 23.35 73 11.35 9.55E-12 0.1113
Nr4a3 38 22.46 48 15.73 2.80E-08 0.7223
Ccl5 39 22.15 36 18.02 1.01E-07 0.2819
Ch25h 40 21.83 65 12.59 9.66E-11 0.2134
Cd40 41 21.42 66 12.25 2.74E-11 0.8623
Cd40 42 21.31 54 13.89 6.89E-12 0.3615
Zc3h12c 43 21.07 28 21.05 3.52E-10 0.7250
Clec4e 44 20.75 29 20.40 2.51E-09 0.9522
Malt1 45 20.22 33 18.56 5.46E-12 0.8940
Hivep3 46 19.93 22 22.60 3.95E-15 0.4636
Ptges 47 19.70 53 14.23 2.23E-10 0.2554
Cd69 48 19.60 34 18.55 3.57E-07 0.5920
Cd40 49 19.48 60 13.08 2.69E-12 0.7930
Traf1 50 19.18 43 16.55 5.61E-08 0.2824
Probe sets from the top 50 induced targets in PnCW-stimulated control cells are ordered 1 through 50 based on fold induction relative to the
untreated control cells at 4 h. The correlative rank of genes expressed in PnCW-stimulated NOD2-deficient macrophages relative to the control
ranking is listed along with the P-values (ANOVA) by time relative to unstimulated cells and by genotype.
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strains of Ripk2 -/- mice and mice lacking both NOD1 and
NOD2 (Nod1-/-;Nod2 -/-) to probe if IL-10 production was
inhibited. We observed by ELISA and qRT-PCR analysis
that RIPK2-deficient cells had a similar phenotype to
NOD2-deficient BMDMs (Fig. 4) in terms of reduced IL-10
production in response to PnCW. Furthermore, macroph-
ages from Nod1-/-;Nod2 -/- mice, which have been
reported to have similar phenotypes to Ripk2-/- macroph-
ages (Park et al., 2007), also had a deficiency in
IL-10 production when stimulated with PnCW. Finally,
when introduced into Nod2 -/- macrophages by retroviral-
mediated transduction, human NOD2 rescued IL-10 in
response to PnCW and MDP responsiveness
(Fig. 4E–G). Analogous studies with NOD1 were not pos-
sible because human NOD1 producer lines do not make
virus at sufficiently high titre to infect stem cells. Collec-
tively, these data provide evidence that NOD2 and RIPK2
function in the same pathway that mediated IL-10 produc-
tion in response to PnCW.
Zymosan, a complex cell wall fraction from yeast, has
been shown to induce IL-10 production by the TLR2-
DECTIN1-SYK pathway and the TLR2-DECTIN1-ERK
pathway (Dillon et al., 2004; 2006; Rogers et al., 2005;
Slack et al., 2007). We therefore asked if PnCW also
stimulated ERK activation with the idea that ERK could be
a common downstream mediator of multiple TLR2-driven
pathways, including the TLR2-NOD2 pathway. However,
we observed that PnCW induced low or negligible
ERK phosphorylation (Fig. 5). Therefore, PnCW seems
to stimulate IL-10 production via pathways distinct
from those induced by zymosan, even though both the
DECTIN1-SYK and NOD2-RIPK2 pathways depend on
TLR2. Finally, IL-10 production in response to PnCW was
dependent on MyD88 (Fig. 5E), suggesting that the
TLR2-MyD88 pathway is absolutely necessary for PnCW-
induced IL-10 production. MyD88 was not, however,
required for MDP sensing (Fig. 5F) as expected as shown
by the use of a sensitive MDP stimulation assay where
nitric oxide production is measured in response to MDP
and IFN-g (Totemeyer et al., 2006). By contrast, MDP
sensing was dependent on NOD2.
Discussion
Our data suggest that NOD2 is a component of a
signalling module that regulates IL-10 production in a
Fig. 2. Absence of NOD2 has a limited effect
on PnCW-induced inflammatory transcription.
A. Select inflammatory targets induced by
PnCW in control or NOD2-deficient BMDMs.
Data for each target mRNA is plotted as the
average difference signal intensity. Data are
averages from independent (n = 4) Affymetrix
arrays performed per genotype and per time.
No significant differences (paired t-test) were
detected between genotypes. Complete data
sets for this experiment have been deposited
in the GEO database.
B. Expression of IL-10 target genes is
affected in the absence of NOD2 function.
Signal intensity for IL-10 (left most in the
panel) and selected genes whose expression
is dependent, in part, on autocrine-paracrine
IL-10 production. *P < 0.05, paired t-test
comparing 4 h time points between control
and Nod2 -/- BMDMs (n = 4).
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stimulus-specific and cell type-specific way (Fig. 6). Acti-
vation of TLR2-MyD88 by Pam3CSK4 leads to ERK acti-
vation and IL-10 induction. In contrast, activation of TLR2-
MyD88 by PnCW invokes NOD2 and RIPK2 and
bypasses ERK activation to produce IL-10. Activation of
TLR2 and DECTIN by zymosan leads to ERK activation
and IL-10 induction. It is well accepted that IL-10 is essen-
tial for regulating the amplitude of most, if not all inflam-
matory responses in vivo. Therefore, mutant forms of
NOD2 may be a component of homeostatic regulation of
IL-10 in myeloid-derived cells. Notably, Netea and col-
leagues have demonstrated that human monocyte-
derived macrophages and dendritic cells isolated from
people bearing NOD2 mutations have reduced IL-10 pro-
duction in response to peptidoglycan and MDP (Netea
et al., 2004; 2005; Kullberg et al., 2008).
We found parallels between PnCW stimulation of IL-10
production and the activation of dendritic cells by
zymosan, a large fragmentary remnant of yeast cell walls.
In both cases, immune cells are exposed to particulate
fractions of cell walls of varying sizes and displaying
a variety of different sugars, lipids and structural
biopolymers. Zymosan stimulates IL-10 production by a
MyD88-independent pathway involving TLR2, DECTIN1,
SYK and ERK (Dillon et al., 2004; 2006; Rogers et al.,
2005; Slack et al., 2007). PnCW stimulation of IL-10 also
requires TLR2, but does not seem to activate substantial
ERK phosphorylation (Fig. 5). Instead, MyD88, NOD2
and RIPK2 are required. The PnCW and zymosan recog-
nition pathways present a considerable contrast to the
activation of immune cells with Pam3CSK4 through TLR2,
a pathway that has an absolute requirement for MyD88
but not NOD2. Therefore, there are different signalling
routes to IL-10 production following TLR2 activation
(Fig. 6). Similarly, additional diversity of signalling for
IL-10 production has been observed for receptors such as
the LPS-mediated pathway that requires TLR4 and p38
(Park et al., 2005), and the immune complex pathway that
enhances IL-10 production via FcR ligation (Edwards
et al., 2006). BTK also plays a key role in stimulus-specific
IL-10 production: the absence of BTK leads to a decrease
in IL-10 produced from macrophages and a correspond-
ing increase in inflammatory mediators normally blocked
by IL-10 (e.g. IL-12, IL-6) (Kawakami et al., 2006; Schmidt
Fig. 3. Pro-inflammatory cytokine
transcription in response to PnCW is
dependent on TLR2. BMDMs from the
indicated genotypes were stimulated with
PnCW for the times shown. Cytokine mRNAs
were measured by qRT-PCR. Data are
representative of three independent
experiments.
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et al., 2006). However, the reduced amounts of IL-10
made in the absence of BTK, like the absence of NOD2,
is insufficient to initiate the severe inflammatory bowel
disease observed in the complete absence of IL-10
(Schmidt et al., 2006) (L.M. and P.J.M., unpubl. data).
Therefore, NOD2 and BTK both seem to function to tune
stimulus-specific IL-10 production.
We found that neither TLR2 nor NOD2 were absolutely
required for PnCW stimulation of IL-10 production. IL-10
was made, although in much lower amounts, in the
absence of either TLR2 or NOD2. However, cells lacking
both TLR2 and NOD2 had a complete abrogation of IL-10
production. These data suggest that TLR2 and NOD2
have a genetic interaction. A similar finding has been
made in the ECOVA gut inflammation system where
pathology observed in the absence of NOD2 was
reversed in the combined deficiency of both NOD2 and
TLR2 (Watanabe et al., 2006). It is however, premature to
Fig. 4. IL-10 expression in response to PnCW is dependent on the RIPK2 pathway.
A. BMDMs from Ripk2 -/- or Nod1 -/-; Nod2-/- mice were stimulated with PnCW and IL-10 measured over time by ELISA.
B. As in (A), but following LPS stimulation.
C and D. Analysis of BMDMs from an independent Ripk2 mutant strain showing IL-10 and IL-10 mRNA produced in response to PnCW
requires RIPK2.
E and F. Reconstitution of Nod2 -/- hematopoietic stem cells with human or mouse NOD2 cDNAs rescues IL-10 production in response to
PnCW. Stem cells from Nod2 -/- mice were infected with retroviruses containing hNOD2 or mNOD2 cDNAs and selected by cell sorting for
YFP and plated into media containing CSF-1 to drive differentiation into macrophages. After differentiation, macrophages were stimulated with
LPS or LPS and MDP to measure the MDP synergy with TLR4 signalling (E) or IFN-g signalling (F) or IL-10 production after PnCW treatment
(G). Data are representation of two independent infection studies. In the case of mNOD2, sufficient cells were obtained to perform the
MDP-IFN-g synergy assay only.
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suggest that TLR2 and NOD2 function in a linear pathway
where NOD2 is downstream of TLR2. Instead, we suggest
that cross-talk between the TLR2 and NOD2 pathways
occurs in a stimulus- and cell-specific context. Cross-talk
is not revealed when TLR2 is stimulated with Pam3CSK4
but instead is exposed by agents such as PnCW and
peptidoglycan, at least in the BMDMs used here. This idea
may help resolve previous reports that suggested that
NOD2 was not involved in TLR2 signalling (Kobayashi
et al., 2005): dependence on both stimulus and cell type is
needed to expose differences among pathways. Recent
data from human monocytes bearing NOD2 mutations
has also revealed a complex interplay between NOD2
and TLR2 (Borm et al., 2008).
Using transcriptome profiling, we also found that the
absence of NOD2 affected a surprisingly low number of
mRNAs when BMDMs were stimulated with PnCW. These
data are in keeping with published studies suggesting that
Fig. 6. Model of IL-10 production myeloid lineage cells
(macrophages and DCs) stimulated by agents that activate TLR2,
alone or in combination with other cell surface molecules.
Fig. 5. PnCW activation of BMDMs does not
activate the ERK or p38 pathways but
requires MyD88 signalling.
A. C57BL/6 BMDMs were stimulated with
Pam3CSK4, LPS or PnCW over time and
ERK phosphorylation measured by
immunoblotting for phosphorylated forms of
ERK or reprobed for total ERK amounts.
B. A similar experiment to (A) was performed
using BMDMs from the genotypes indicated
on the right.
C. The same lysates from (B) were probed for
phospho-p38. Note that PnCW does not
activate ERK or p38 in any of these
experiments.
D. BMDMs from control, Nod2 -/-, Tlr2 -/- or
MyD88 -/- mice were stimulated with PnCW
for 8 h and IL-10 measured by ELISA. Data
are average  SD from independent samples
(n = 3).
E. BMDMs were stimulated with MDP or
MDP + IFN-g overnight and nitrites measured
by the Griess assay. Stimulation with IFN-g
alone did not produce detectable nitrites (data
not shown).
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loss of NOD2 has minimal effects on pro-inflammatory
TLR signalling (Pauleau and Murray, 2003; Kobayashi
et al., 2005; Park et al., 2007). However, PnCW is an
example of a pathogen ‘signal’ that can activate multiple
pathways including the TLR2 pathway. It is not surprising
that NOD2 plays limited roles in the overall transcriptional
response as the mammalian immune system most likely
has developed multiple, overlapping ways to recognize
and respond to such a complex material. Nevertheless,
the finding that IL-10 was one of the most affected
mRNAs, along with a cohort of IL-10-regulated genes,
suggests that further work is warranted to determine the
role of NOD2 in IL-10 production in humans bearing muta-
tions in NOD2.
It is tempting to speculate that IL-10 regulation has key
functional significance in chronic inflammatory states
such as the inflammatory bowel diseases. Most research-
ers agree that common pathways of inflammatory media-
tor production, arrived at by a multitude of genetic and
environmental mechanisms, drive disease and are the
central focus of therapeutic intervention through anticy-
tokine antagonists. IL-10 plays an essential regulatory
role in controlling the products of the common inflamma-
tory pathway: IL-12, TNF-a, IL-6, etc. Therefore, small
disturbances in temporal, anatomic or quantitative IL-10
amounts may translate into greater inflammation.
Experimental procedures
Mice
Nod2 - /- mice have been previously described (Pauleau and
Murray, 2003). Nod2 - /-;Tlr2 - /- mice on a C57BL/6 background
(n = 5 generations) have been described (Watanabe et al.,
2006). Tlr2 - /- mice were purchased from the Jackson
Laboratories. Mice were bred and genotyped according to pub-
lished protocols. For some experiments, Nod2 - /- mice were
backcrossed 10 generations to the C57BL/6 background. All
animal experiments were performed in accordance with protocols
governed by the St Jude Animal Care and Use Committee (P.J.
M., Principal Investigator). Nod1 - /-;Nod2 - /- and Rip2k - /- mice
have been described previously (Chin et al., 2002; Kobayashi
et al., 2002; Park et al., 2007).
Cell preparation and stimulus conditions
Bone marrow-derived macrophages were isolated and cultured
as described (Lang et al., 2002). Macrophages were stimulated
with highly purified PnCW prepared as described previously
(Tuomanen et al., 1985a,b). Briefly, S. pneumoniae unencapsu-
lated strain R6 were grown in C+Y medium, bacteria were boiled
in SDS, mechanically broken by shaking with acid-washed glass
beads, and treated sequentially with DNase, RNase, trypsin, LiCl,
EDTA and acetone. PnCW was confirmed to be free of protein by
analysis for non-cell wall amino acids using mass spectrometry.
The absence of contaminating endotoxin was confirmed first by
the Limulus test (Associates of Cape Cod) and then by ELISA
measurement of hIL-8 production by HEK 293 cells transfected
with plasmids designed to express TLR4 and MD2 (a generous
gift of Dr Doug Golenbock, UMass) in the presence of purified
PnCW. For fluorescence microscopy experiments, BMDMs
were labelled with Phalloidin and 4′,6-diamidino-3-phenylindole
(DAPI), a nuclear stain. PnCW was directly labelled with
1 mg ml-1 FITC (Sigma-Aldrich) solution in carbonate buffer
(pH 9.2) for 1 h at room temperature in the dark and washed
twice with PBS containing calcium and magnesium (Gosink et al.,
2000).
ELISA
ELISA was performed as previously described (El Kasmi et al.,
2006). Capture and detection antibodies used were purchased
from BD Pharmingen. Detection limits for the ELISAs were
50 pg ml-1 (IL-10) and 10 pg ml-1 (IL-12p40).
Northern blotting, RT-PCR and immunoblotting
Total RNA was isolated from primary macrophages using Trizol.
Reverse transcription (qRT-PCR) was performed as described
previously using primers and probes (Applied Biosciences) spe-
cific for each cytokine mRNA (Lang et al., 2002). Immunoblotting
was performed using the following rabbit polyclonal antibodies:
antiphospho-p42, p44 ERK and anti-phospho-p38 from Cell Sig-
naling Technology used at 1:500 final dilution. Anti-p42, p44 ERK
and anti-p38 were from the same source and were used at a final
concentration of 1:1000.
Transcriptome analysis
RNA samples from BMDM cultures representing four PnCW
preparations, two genotypes (wild-type and the NOD2 deficient)
and three time points (0, 1 and 4 h) were arrayed on Affymetrix
GeneChip analysis murine 430v2GeneChip arrays. Signal was
acquired with MAS5.0 software and natural log transformed
[ln(signal + 20)] to stabilize variance and better conform the data
to the normal distribution. Principal components analysis (Partek
6.1) revealed a batch effect which, being orthogonal to hour and
genotype, was removed by capturing and mean adjusting residu-
als of a one-way ANOVA-based on PnCW batch (STATA/SE 9.2).
The batch-corrected transformed signal was tested for exposure
time and genotype effects in a two-way ANOVA using Partek. The
P-values for the time effect were corrected for multiple compari-
sons using the false discovery rate (Benjamini et al., 2001). Fold
change calculations were based on the geometric means of the
batch corrected data between the 4 h and 0 h time points for
each genotype. Array data has been submitted to the GEO data-
base (accession GSE8960).
Retroviral-mediated transduction of stem cells
Retroviral transduction of murine bone marrow cells was per-
formed as described previously (El Kasmi et al., 2006; Holst
et al., 2006a,b). For the transduction experiments, we used fetal
liver stem cells isolated from E14 pregnant Nod2 - /- female mice.
Fetal liver cells were cultured for 48 h in complete DMEM with
20% FBS, 20 ng ml-1 murine IL-3, 50 ng ml-1 human IL-6 and
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50 ng ml-1 murine stem cell factor (BioSource International).
Stem cells were subsequently co-cultured for a further 48 h with
irradiated (1200 rad) retroviral producer cell lines plus 6 mg ml-1
polybrene and cytokines as previously detailed. Non-adherent,
transduced cells were collected, red and re-suspended in PBS
with 2% FBS with 20 U ml-1 heparin. Cells were sorted by gating
on forward and side scatter, and YFP positivity. Cells were sub-
sequently plated out with 500 ng ml-1 Fungizone and 25 mg ml-1
gentamicin in complete DMEM with 20% FBS and L cell condi-
tioned medium as a source of CSF-1. Following differentiation,
mature cells were measured by flow cytometry for YFP along with
surface markers (CD11b, F4/80) for macrophages.
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